XML 15 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adopted a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408.

 

On September 20, 2024, Christopher Heery, our Chief Medical Officer, terminated a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c), which had been adopted as of December 22, 2023.

Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Christopher Heery  
Trading Arrangements, by Individual  
Name Christopher Heery
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 22, 2023
Rule 10b5-1 Arrangement Terminated true
Termination Date September 20, 2024